Back to companies
RELMADA THERAPEUTICS, INC.
RLMDUSNASDAQPharmaceuticals & HealthcareRELMADA THERAPEUTICS, INC.
Revenue
—
FY2025
Operating income
-$59.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API